Seasoned investor and operator focused on growth-stage technology and consumer businesses, combining operating experience with active early-stage deal sourcing and board involvement. Dorota Dziugiell is known for driving commercial scaling, go-to-market strategy and cross-border expansion for portfolio companies; profile typically aligns with VC or growth equity roles and independent advisory work. Market-relevant strengths include strategic partnerships, revenue operations and talent recruitment to support rapid revenue inflection and exit readiness.
Seasoned investor and operator focused on growth-stage technology and consumer businesses, combining operating experience with active early-stage deal sourcing and board involvement. Dorota Dziugiell is known for driving commercial scaling, go-to-market strategy and cross-border expansion for portfolio companies; profile typically aligns with VC or growth equity roles and independent advisory work. Market-relevant strengths include strategic partnerships, revenue operations and talent recruitment to support rapid revenue inflection and exit readiness.
Focuses on growth-stage tech and consumer opportunities where operator-led value creation accelerates commercial scale. Prioritizes companies with repeatable go-to-market motion, clear unit economics and cross-border expansion potential, deploying growth-equity or active VC capital alongside board-level engagement. Investment decisions hinge on measurable revenue ops levers, strategic partnerships and founding-team recruitability. Time horizon is medium-term growth to liquidity, with disciplined staging of follow-on capital, KPI-driven milestones, and an emphasis on exit readiness through revenue inflection.
Focuses on growth-stage tech and consumer opportunities where operator-led value creation accelerates commercial scale. Prioritizes companies with repeatable go-to-market motion, clear unit economics and cross-border expansion potential, deploying growth-equity or active VC capital alongside board-level engagement. Investment decisions hinge on measurable revenue ops levers, strategic partnerships and founding-team recruitability. Time horizon is medium-term growth to liquidity, with disciplined staging of follow-on capital, KPI-driven milestones, and an emphasis on exit readiness through revenue inflection.
| Trades 1499 | Longs Won 965/1499 64% | Profit Factor 3.6 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $1.18M |
| Average Win $401,602.24 | Best Trade (Oct 14) $24.41M | Sharpe Ratio -8.74 |
| Average Loss -$201,605.44 | Worst Trade (Jun 29) -$5.73M | Z-Score -3.33 (100%) |
| Commissions $0 | Avg. Trade Length 1y 3m 3w 1d | Expectancy $186,717.05 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 1,953 | 1,758 | 1,563 | 1,367 | 1,172 | 977 | 781 | 586 | 391 | 195 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 72,000 | $18.88M | $24.97M | - | $6.09M | 32.28% | -0.398% |
AMD Advanced Micro Devices Inc. | 60,800 | $9.47M | $31.41M | - | $21.95M | 231.83% | +1.723% |
AMZN Amazon.com Inc | 110,000 | $22.61M | $27.31M | - | $4.7M | 20.78% | -0.839% |
ARVN Arvinas, Inc. | 57,500 | $4.55M | $417,404 | - | -$4.14M | -90.83% | -5.969% |
CCCC C4 Therapeutics, Inc. | 85,000 | $2.42M | $261,800 | - | -$2.16M | -89.18% | -3.145% |
COP ConocoPhillips | 38,000 | $4.84M | $5.75M | - | $914,660 | 18.91% | +3.928% |
CRM Salesforce, Inc. | 71,000 | $12.68M | $17.64M | - | $4.96M | 39.11% | -0.713% |
DASH DoorDash, Inc. Class A Common Stock | 50,110 | $13.63M | $9.1M | - | -$4.53M | -33.22% | -2.31% |
DECK Deckers Outdoor Corporation | 51,110 | $5.18M | $4.1M | - | -$1.08M | -20.79% | -5.84% |
FCX Freeport-McMoRan Inc. | 178,290 | $5.81M | $11.69M | - | $5.88M | 101.24% | +1.548% |
GOOGL Alphabet Inc | 112,540 | $25.91M | $36.16M | - | $10.26M | 39.59% | -0.885% |
LOGI Logitech International S.A. | 23,673 | $2.12M | $2.6M | - | $480,874.19 | 22.68% | -2.356% |
MCHP Microchip Technology Inc. | 105,000 | $6.69M | $7.8M | - | $1.11M | 16.63% | -0.275% |
MRVL Marvell Technology Inc. | 115,000 | $5.43M | $26.28M | - | $20.85M | 384% | +2.253% |
MSCI MSCI Inc. | 11,170 | $6.34M | $6.87M | - | $536,438.95 | 8.46% | -0.775% |
MSFT Microsoft Corporation Common Stock | 76,500 | $28.32M | $40.07M | - | $11.75M | 41.5% | +0.522% |
MU Micron Technology Inc. | 31,000 | $2.86M | $27.23M | - | $24.37M | 852.7% | +2.557% |
NBIX Neurocrine Biosciences, Inc. | 30,400 | $2.96M | $4.33M | - | $1.37M | 46.25% | -0.705% |
NOW ServiceNow Inc. | 80,500 | $8.24M | $12.72M | - | $4.47M | 54.22% | +0.611% |
NRIX Nurix Therapeutics, Inc. | 85,000 | $754,800 | $2.15M | - | $1.39M | 184.68% | -0.902% |